鼻气道阻塞研究(NAIROS):鼻中隔矫正术与药物治疗鼻中隔偏曲伴鼻塞的III期开放标签混合方法多中心随机对照试验
NAIROS试验旨在评估鼻中隔矫正术与药物治疗对成人鼻中隔偏曲伴鼻塞的临床有效性和成本效益。研究计划招募378例患者,1:1随机分组,主要结局为6个月时SNOT-22总分,随访12个月。
要点
- 鼻中隔矫正术临床有效性证据有限,NAIROS试验将填补这一空白。
- 纳入标准包括鼻内镜下可见鼻中隔偏曲且NOSE问卷症状评分≥30。
- 主要结局为6个月时SNOT-22总分,并随访12个月评估临床与经济结局。
核心结论
- NAIROS试验将评估鼻中隔矫正术与药物治疗对成人鼻中隔偏曲伴鼻塞的临床有效性和成本效益。
研究设计与样本
- 多中心、混合方法、开放标签、随机对照试验,计划从苏格兰、英格兰和威尔士最多17个中心招募378例患者。
- 纳入标准为鼻内镜下可见鼻中隔偏曲且NOSE问卷评分≥30的成人鼻塞患者。
- 按1:1随机分组,按性别和严重程度(NOSE评分)分层,随访12个月。
关键数值与推荐
- 主要结局指标为6个月时SNOT-22总分。
- 手术治疗为鼻中隔矫正术,可伴或不伴解剖学较宽侧下鼻甲减容。
- 药物治疗为鼻用生理盐水喷雾后使用含氟激素喷雾,每日一次,持续6个月。
临床怎么用
- 研究结果将帮助识别最可能从手术获益的个体,避免低获益可能性的不必要手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Septoplasty (surgery to straighten a deviation in the nasal septum) is a frequently performed operation worldwide, with approximately 250,000 performed annually in the US and 22,000 in the UK. Most septoplasties aim to improve diurnal and nocturnal nasal obstruction. The evidence base for septoplasty clinical effectiveness is hitherto very limited. AIMS: To establish, and inform guidance for, the best management strategy for individuals with nasal obstruction associated with a deviated septum. METHODS/DESIGN: A multicentre, mixed-methods, open label, randomised controlled trial of septoplasty versus medical management for adults with a deviated septum and a reduced nasal airway. Eligible patients will have septal deflection visible at nasendoscopy and a nasal symptom score ≥ 30 on the NOSE questionnaire. Surgical treatment comprises septoplasty with or without reduction of the inferior nasal turbinate on the anatomically wider side of the nose. Medical management comprises a nasal saline spray followed by a fluorinated steroid spray daily for six months. The recruitment target is 378 patients, recruited from up to 17 sites across Scotland, England and Wales. Randomisation will be on a 1:1 basis, stratified by gender and severity (NOSE score). Participants will be followed up for 12 months post randomisation. The primary outcome measure is the total SNOT-22 score at 6 months. Clinical and economic outcomes will be modelled against baseline severity (NOSE scale) to inform clinical decision-making. The study includes a recruitment enhancement process, and an economic evaluation. DISCUSSION: The NAIROS trial will evaluate the clinical effectiveness and cost-effectiveness of septoplasty versus medical management for adults with a deviated septum and symptoms of nasal blockage. Identifying those individuals most likely to benefit from surgery should enable more efficient and effective clinical decision-making, and avoid unnecessary operations where there is low likelihood of patient benefit. TRIAL REGISTRATION: EudraCT: 2017-000893-12, ISRCTN: 16168569. Registered on 24 March 2017.
引用
- Rennie KJ, O'Hara J, Rousseau N, et al. Nasal Airway Obstruction Study (NAIROS): a phase III, open-label, mixed-methods, multicentre randomised controlled trial of septoplasty versus medical management of a septal deviation with nasal obstruction. Trials. 2020. PMID: 32054508. doi:10.1186/s13063-020-4081-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。